{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Genomic Sequencing Initiative Advances Angiosarcoma Research
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information on recent research pertaining to angiosarcoma.Learning Objectives
After completing this continuing education activity you will be able to:
- Synthesize recent discoveries from the Angiosarcoma Project.
- Identify characteristics of angiosarcoma and social media-based work on angiosarcoma and other rare cancers.
Disclosures
The author(s), faculty, staff, and planners, including spouses/partners (if any), in any position to control the content of this activity, have disclosed that they have no financial relationships with, or financial interests in, any commercialcompanies relevant to this educational activity
Price:
$12.95
Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: OT0620
Published: June 2020
Expires: 6/7/2024
Sources:
Oncology Times
Required Passing Score: 8/10 (80%)
Topics:
Angiosarcoma
,
Genomics